In a historic medical first, a man with diabetes has begun producing insulin naturally after receiving gene-edited pancreatic cells—a breakthrough that could redefine how the disease is treated. Instead of relying on constant injections or pumps, these engineered cells are designed to function like healthy pancreatic tissue, sensing blood sugar levels and releasing insulin automatically. The implanted cells replicate the body’s natural glucose-control system. When blood sugar rises, they respond